However, this rapid globalization of commerce presents challenges to regulators who oversee the safety and quality of medical products. Many of these challenges manifest themselves in China. As FDA's country director for the People's Republic of China, I testified on April 3, 2014 before the U.S.-China Economic and Security Review Commission, an advisory panel created by Congress, on our work to ensure the safety and quality of medical products produced in China and imported into the United States.
For advertising or promotion on HealthNewsDigest.com, call Mike McCurdy at: 877-634-9180. We have over 7,000 journalists as subscribers and may use our content